A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients

被引:10
|
作者
Goodney, Philip P. [1 ]
Chang, Robert W. [1 ]
Cronenwett, Jack L. [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Vasc Surg Sect, Lebanon, NH 03765 USA
关键词
D O I
10.1016/j.jvs.2008.06.061
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Complications following percutaneous femoral access arc a significant source of morbidity and cost in patients undergoing peripheral vascular interventions. Our purpose in this study is to determine if access complications could be reduced by the use of a standardized protocol. Methods: We studied prospectively 210 consecutive patients in our vascular surgery practice undergoing peripheral arterial interventions via percutaneous retrograde femoral access. First, we prospectively collected data to determine current outcomes during a 4-month observation phase. Based oil these experiences, we designed and implemented a uniform arterial closure protocol, with closure device use guided by sheath size, arterial calcification, and previous groin scarring. Our main outcome measures were major complications (need for operation) or minor complications (access site bleeding or hematoma). Outcomes were compared between the two phases using chi-squared analysis and analysis of variance (ANOVA). Results: In the observation phase, 119 patients underwent 140 arterial punctures, and in the postprotocol phase, we performed 112 punctures in 91 patients. Between the observation and postprotocol phases, patient demographics were similar; average sheath size was unchanged (sheaths over 6F 6% vs 8%, respectively, P = .55), and percentage of patients receiving heparin did not change significantly (76% vs, 86%, P = .08). No major complications occurred in either the observation or the postprotocol phases. While 24 minor complications occurred in the observation phase, only seven minor complications Occurred in the postprotocol phase (17% vs 7%, P < .02). Closure device use decreased with protocol implementation (57% to 32%, P < .01), but closure device failures also decreased from 23% to 7% (P < .01). Conclusions: Process improvement, achieved by instituting a standardized percutaneous arterial closure protocol based oil selective closure device use guided by sheath size, arterial calcification, and previous access scarring. Implementation of our protocol resulted in a decrease in the incidence of minor complications at the access site and refined patient selection for closure device use. (J Vasc Surg 2008;48:1481-88.)
引用
收藏
页码:1481 / 1488
页数:8
相关论文
共 50 条
  • [31] Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population
    Kerre, Steven
    Kustermans, Lise
    Vandendriessche, Tom
    Bosmans, Johan
    Haine, Steven E.
    Miljoen, Hielko
    Vrints, Christiaan J.
    Beutels, Philippe
    Wouters, Kristien
    Claeys, Marc J.
    EUROINTERVENTION, 2014, 10 (02) : 191 - 197
  • [32] Arterial Closure Devices Versus Manual Compression After Endovascular Interventions for Peripheral Artery Disease
    Fokkema, Margriet
    Minnee, Robert C.
    Kock, Gert-Aldert H.
    Vahl, Anco
    Leijdekkers, Vanessa J.
    JOURNAL OF VASCULAR SURGERY, 2015, 61 (06) : 131S - 131S
  • [33] Infectious and ischemic complications from percutaneous closure devices used after vascular access
    Boston, US
    Panneton, JM
    Hofer, JM
    Sabater, EA
    Caplice, N
    Rowland, CM
    Noel, AA
    Bower, TC
    Cherry, KJ
    Gloviczki, P
    ANNALS OF VASCULAR SURGERY, 2003, 17 (01) : 66 - 71
  • [34] Vascular access site complications in the contemporary practice of percutaneous coronary interventions: Impact of closure devices and bivalirudin
    Mishra, S
    Wolfram, RM
    Xue, ZY
    Kuchulakanti, PK
    Satler, LF
    Pichard, AD
    Suddath, W
    Kent, K
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 33B - 33B
  • [35] Local and systemic complications after percutaneous interventions in the treatment of peripheral arterial occlusive disease
    Heller, A.
    Meisenbacher, K.
    Dovzhanskiy, D.
    Uhl, C.
    Billing, A.
    Boeckler, D.
    GEFASSCHIRURGIE, 2021, 26 (03): : 219 - 224
  • [36] Comments regarding 'Influence of Use of a Vascular Closure Device on Incidence and Surgical Management of Access Sites. Complications after Percutaneous Interventions'
    Dosluoglu, H. H.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2011, 42 (02) : 236 - 237
  • [37] Predictors of access-site complications among patients treated with femoral closure devices after percutaneous coronary interventions
    Cura, FA
    Roffi, M
    Albirini, A
    Schneider, JP
    Raymond, RR
    Franco, I
    Silver, MS
    Yadav, JS
    Withlow, PL
    CIRCULATION, 2000, 102 (18) : 425 - 425
  • [38] Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors
    Resnic, FS
    Blake, GJ
    Ohno-Machado, L
    Selwyn, AP
    Popma, JJ
    Rogers, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (05): : 493 - 496
  • [39] Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device
    Steppich, Birgit
    Stegmueller, Felix
    Rumpf, Philipp Moritz
    Pache, Juergen
    Sonne, Carolin
    Lesevic, Hasema
    Braun, Daniel
    Hausleiter, Joerg
    Kasel, Albert Markus
    Ott, Ilka
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (02) : 223 - 229
  • [40] Arterial Closure vs Direct Compression for Hemostasis After Percutaneous Coronary Interventions - The ACDC Trial
    Cheema, Asim N.
    Dehghani, Payam
    Jolly, Sanjit S.
    Hong, Tony
    Mohammad, Atif
    Chisholm, Robert J.
    Kutryk, Michael J. B.
    Fam, Neil P.
    Hutchison, Stuart
    Leong-Poi, Howard
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 83D - 84D